Merck KGaA (MRK) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free MRK Stock Alerts €150.10 -2.25 (-1.48%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartHeadlinesStock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMerck & Co Stock (NYSE:MRK), Analyst Ratings, Price Targets, Predictionsbenzinga.com - April 19 at 1:33 PMHealth Canada Approves Merck's Keytruda Plus Chemotherapy To Treat Gastric Cancersmarkets.businessinsider.com - April 19 at 8:33 AMUnveiling 17 Analyst Insights On Merck & Cobenzinga.com - April 18 at 3:17 PMMerck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.msn.com - April 14 at 8:40 AMMerck & Company: Balancing Growth Prospects Against Rising Operational Challengesmarkets.businessinsider.com - April 12 at 9:42 AMMerck & Company (MRK) Receives a Buy from Cantor Fitzgeraldmarkets.businessinsider.com - April 6 at 8:12 AMMerck Begins Phase 3 Trial Of MK-1084 As First-Line Treatment Of Certain Metastatic NSCLC Patientsmarkets.businessinsider.com - April 4 at 7:42 AMMerck Stock Hits Record High as FDA Approves Its Cardiovascular Disease Drugmsn.com - March 28 at 8:36 PMFDA Approves Merck's Winrevair For Treatment Of Pulmonary Arterial Hypertension In Adultsmarkets.businessinsider.com - March 27 at 10:59 AMMerck & Co., Inc.: Merck Foundation Strengthens Its Commitment to Expanding Access to Care in Asia-Pacific Regionfinanznachrichten.de - March 26 at 10:23 AMMerck KGaA (ETR:MRK) Is Paying Out A Dividend Of €2.20finance.yahoo.com - March 19 at 4:06 AMMerck hits main goal for Keytruda in late-stage trial for cervical cancermsn.com - March 15 at 8:13 AMSociete General cuts Merck to sell, cites Keytruda patent expirymsn.com - March 11 at 6:46 PMMerck KGaA Expects Organic Sales, Earnings Growth This Yearfinance.yahoo.com - March 7 at 7:37 AMC4 Therapeutics, Inc.: C4 Therapeutics Announces Strategic Discovery Research Collaboration withfinanznachrichten.de - March 4 at 10:05 AMCritical Insights From Merck & Co Analyst Ratings: What You Need To Knowmarkets.businessinsider.com - February 29 at 3:01 PMMerck: A Great Dividend Growth Stock, But Not At This Priceseekingalpha.com - February 29 at 8:19 AMBehind the Scenes of Merck & Co's Latest Options Trendsbenzinga.com - February 26 at 11:42 AMMerck KGaA (MRK.BE)finance.yahoo.com - February 24 at 10:30 AMMerck: FDA Grants Priority Review To SBLA For KEYTRUDA Plus Chemotherapy In Endometrial Carcinomamarkets.businessinsider.com - February 20 at 1:03 PMMerck Says Health Canada Oks KEYTRUDA In Combination With Trastuzumab And Chemotherapymarkets.businessinsider.com - February 12 at 7:24 AMM & A News: Merck (NYSE:MRK) Snaps Up Elanco’s Aqua Unit for $1.3Bmsn.com - February 5 at 3:34 PMMerck Posts Surprise Quarterly Profit Against An Expected Loss, Oncology And Vaccines Drive Growthbenzinga.com - February 1 at 11:58 AMMerck Non-GAAP EPS of $0.03 beats by $0.14, revenue of $14.6B beats by $120Mmsn.com - February 1 at 11:58 AMMerck’s fourth-quarter results top estimates, fueled by key cancer drugs and vaccinesmsn.com - February 1 at 6:57 AMMerck posts better-than-expected quarterly results on soaring Keytruda salesreuters.com - February 1 at 6:57 AMMerck results beat expectations as top drugs Keytruda, Gardasil post strong salesmsn.com - February 1 at 6:57 AMInvestor Optimism Around Keytruda Drives Merck Stock To Golden Cross Ahead of Earningsmsn.com - January 29 at 6:16 PMMerck's Multi-Billion Cancer Drug Keytruda Improves Disease-Free Survival In Advanced Bladder Cancer After Surgery, Data Showsmsn.com - January 28 at 9:35 AMMerck (NYSE:MRK): FDA Approves Expanded Use of Keytrudamsn.com - January 15 at 10:04 AMFDA approves Merck's Keytruda for FIGO 2014 cervical cancermsn.com - January 12 at 6:55 PMMerck's Keytruda combo gets FDA nod for expanded use in cervical cancerreuters.com - January 12 at 6:55 PMMilliporeSigma's Global Food Drive Provides 535,685 Mealsfinanznachrichten.de - January 10 at 1:17 PMBuy Rating for Merck on Strategic Acquisition of Harpoon Therapeutics and Promising Drug Efficacymarkets.businessinsider.com - January 10 at 7:36 AMMerck (MRK) Advances But Underperforms Market: Key Factsmsn.com - January 8 at 8:51 PMMerck in talks to acquire Harpoon Therapeutics for around $700M - Bloombergmsn.com - January 8 at 8:27 AMP/E Ratio Insights for Merck & Cobenzinga.com - January 5 at 2:36 PMMerck stock poised for sixth straight gain, Cowen upgrades on valuationmsn.com - January 4 at 7:01 PMMerck stock poised for sixth straight gainmsn.com - January 4 at 2:01 PMWhy the Market Dipped But Merck (MRK) Gained Todaymsn.com - January 3 at 7:34 PMMerck to Participate in the 42nd Annual J.P. Morgan Healthcare Conferencebusinesswire.com - January 3 at 8:10 AMWhat's Next as Shares of Merck Surge to the Upside?realmoney.thestreet.com - January 3 at 8:10 AMPro Research: Wall Street delves into biopharmaceutical leaderin.investing.com - January 2 at 10:01 AMMRK Factor-Based Stock Analysisnasdaq.com - December 30 at 12:57 AMMerck: Smart Value For Potentially Strong Total Returnsseekingalpha.com - December 25 at 12:41 PMMerck: FDA Says Gefapixant NDA Did Not Meet Substantial Evidence Of Effectiveness To Treat RCC, UCCnasdaq.com - December 21 at 6:32 AMUS FDA approves Merck's drug for kidney cancermsn.com - December 15 at 8:35 PMMerck gets FDA approval for kidney cancer drug Weliregmsn.com - December 15 at 8:35 PMFDA Approves Merck's Drug Belzutifan For Type Of Advanced Kidney Cancer In Pretreated Cancer Patientsmsn.com - December 15 at 10:34 AMModerna, Merck Treatment Effective in Fighting Cancermsn.com - December 14 at 1:09 PM Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address What is the 72-Hour Profit Surge? (Ad)One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge… Click here now to get all the details. MRK Media Mentions By Week MRK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MRK News Sentiment▼0.140.34▲Average Medical News Sentiment MRK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MRK Articles This Week▼23▲MRK Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MRK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Bayer Aktiengesellschaft News Today Fresenius Medical Care News Today Carl Zeiss Meditec News Today Siemens Healthineers News Today Evotec News Today Gerresheimer News Today MorphoSys News Today Shop Apotheke Europe News Today CompuGroup Medical SE & Co. KGaA News Today Biotest Aktiengesellschaft News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ETR:MRK) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
